Causes of Troponin Elevation and Associated Mortality in Young Patients.

[1]  B. Kissela,et al.  Prevalence of Positive Troponin and Echocardiogram Findings and Association With Mortality in Acute Ischemic Stroke , 2017, Stroke.

[2]  Deepak L. Bhatt,et al.  Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk , 2017, American Journal of Nephrology.

[3]  Deepak L. Bhatt,et al.  Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines–Heart Failure Program , 2017, JAMA cardiology.

[4]  R. D'Agostino,et al.  Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography , 2017, Circulation.

[5]  Deepak L. Bhatt,et al.  Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial. , 2016, JAMA cardiology.

[6]  Deepak L. Bhatt,et al.  Elevated Troponin Levels in Stable Patients Undergoing Hemodialysis: A Red Flag or a Red Herring? , 2016, American Journal of Nephrology.

[7]  S. Weiss,et al.  The meaning of elevated troponin I levels: not always acute coronary syndromes. , 2016, The American journal of emergency medicine.

[8]  G. Tognoni,et al.  Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock* , 2015, Critical care medicine.

[9]  Deepak L. Bhatt,et al.  Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. , 2015, The New England journal of medicine.

[10]  M. Shanks,et al.  Troponin rise in hospitalized patients with nonacute coronary syndrome: retrospective assessment of outcomes and predictors. , 2015, The Canadian journal of cardiology.

[11]  D. Bach,et al.  Reliable Exclusion of Acute Coronary Syndrome Among Hospitalized Patients With Elevated Troponin , 2014, Clinical cardiology.

[12]  C. Ramaciotti,et al.  Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen , 2013, Cardiology in the Young.

[13]  Neha J. Pagidipati,et al.  Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement , 2013, Circulation.

[14]  Deepak L. Bhatt,et al.  Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. , 2012, The American journal of medicine.

[15]  J. Rome,et al.  Chest pain with elevated troponin assay in adolescents , 2012, Cardiology in the Young.

[16]  S. Yusuf,et al.  Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy , 2012, Circulation.

[17]  A. Jaffe,et al.  High-sensitive troponin T measurements: what do we gain and what are the challenges? , 2012, European heart journal.

[18]  Daniel A. Hirsh,et al.  Use of Troponin as a Screen for Chest Pain in the Pediatric Emergency Department , 2012, Pediatric Cardiology.

[19]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[20]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[21]  Shih-Huang Lee,et al.  Acute ST‐elevation Myocardial Infarction in Young Patients: 15 Years of Experience in a Single Center , 2010, Clinical cardiology.

[22]  P. Langhorne,et al.  Elevated Troponin after Stroke: A Systematic Review , 2009, Cerebrovascular Diseases.

[23]  W. Markiewicz,et al.  Cardiac troponin I elevation in hospitalized patients without acute coronary syndromes. , 2008, The American journal of cardiology.

[24]  Zachary D. Tebb.  Prognostic Value of Troponins in Acute Pulmonary Embolism: A Meta-Analysis , 2007 .

[25]  Hugo A Katus,et al.  Differential diagnosis of elevated troponins , 2006, Heart.

[26]  S. Mayer,et al.  Cardiac Troponin Elevation, Cardiovascular Morbidity, and Outcome After Subarachnoid Hemorrhage , 2005, Circulation.

[27]  K. Mani,et al.  Death begets failure in the heart. , 2005, The Journal of clinical investigation.

[28]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[29]  C. Baillard,et al.  Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease , 2003, Intensive Care Medicine.

[30]  W. Peacock,et al.  Cardiac troponins in renal insufficiency: review and clinical implications. , 2002, Journal of the American College of Cardiology.

[31]  Fred S Apple,et al.  Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease , 2002, Circulation.

[32]  S. Mayer,et al.  Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage , 1994, Neurology.

[33]  M. Samuels,et al.  Neurogenic heart disease: a unifying hypothesis. , 1987, American Journal of Cardiology.

[34]  E. Gilpin,et al.  Myocardial infarction in young patients: an analysis by age subsets. , 1986, Circulation.

[35]  J. Alpert,et al.  The third universal definition of myocardial infarction , 2013 .

[36]  Dean Karavite,et al.  Acute myocardial infarction in the young--The University of Michigan experience. , 2002, American heart journal.